Status:
COMPLETED
Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
MRC/UVRI and LSHTM Uganda Research Unit
Medical Research Council
Conditions:
HIV/AIDS
Eligibility:
FEMALE
15-24 years
Phase:
NA
Brief Summary
The main aim is to develop and assess an intervention to enhance initiation and adherence to PrEP among HIV negative young women of high risk (YWHR). The specific aims are (1) To conduct formative res...
Eligibility Criteria
Inclusion
- Female age 15- to 24-years old
- Engaging in high-risk sexual behavior having had sex at least once in last three months, --HlV-negative
- Agree to participate in a minimum of four interviews over a 12-month period; including baseline
- Willing to receive services at Good Health for Women Project (GHWP)
- For those initiating PrEP (Truvada):
- Participants should have immunity to Hepatitis B infection and serum creatinine before
- Contra-indications for starting Truvada to be considered include Creatinine \> 1.2 ( (mgldl) or 0.106 (mmolil) and a weight below 35kg.
Exclusion
- Inability to consent to participation in the study
- Condition impeding participation in the study, including severe mental reason to the discretion of the principal investigator, cognitive impairment or illness; serious medical illness or developmental disability and any other reason to the discretion of the principal investigator.
Key Trial Info
Start Date :
July 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04030520
Start Date
July 8 2019
End Date
October 31 2021
Last Update
July 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uganda Virus Research Institute
Entebbe, Uganda